- Conditions
- Degenerative Disc Disease
- Interventions
- Placebo, AMG0103
- Drug
- Lead sponsor
- AnGes, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 6
- States / cities
- Los Angeles, California • San Diego, California • St. Petersburg, Florida + 2 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–7
of 7
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Arterial Occlusive Disease, Peripheral Vascular Disease, Ischemia, Ulcers
- Interventions
- HGF plasmid, Placebo
- Genetic
- Lead sponsor
- AnGes USA, Inc.
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2008
- U.S. locations
- 4
- States / cities
- Pensacola, Florida • Indianapolis, Indiana • Boston, Massachusetts + 1 more
- Conditions
- Arterial Occlusive Disease, Peripheral Vascular Disease, Ischemia
- Interventions
- HGF plasmid
- Genetic
- Lead sponsor
- AnGes USA, Inc.
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 104 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2007
- U.S. locations
- 24
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 19 more
- Conditions
- Critical Limb Ischemia, Vascular Diseases, Peripheral Arterial Disease
- Interventions
- HGF Plasmid
- Biological
- Lead sponsor
- AnGes USA, Inc.
- Industry
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2018
- U.S. locations
- 1
- States / cities
- Lebanon, New Hampshire
- Conditions
- Critical Limb Ischemia
- Interventions
- Subjects from Study AG-CLI-0206 who received AMG0001
- Biological
- Lead sponsor
- AnGes USA, Inc.
- Industry
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Lebanon, New Hampshire
- Conditions
- Critical Limb Ischemia
- Interventions
- HGF Plasmid (AMG0001), Matching Placebo
- Biological
- Lead sponsor
- AnGes USA, Inc.
- Industry
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 28
- States / cities
- Tucson, Arizona • Little Rock, Arkansas • La Jolla, California + 23 more
- Conditions
- Peripheral Artery Disease, Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease, Chronic Limb Threatening Ischemia, Ischemic Ulcer of Foot
- Interventions
- AMG0001, Placebo
- Biological
- Lead sponsor
- AnGes USA, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 20
- States / cities
- Carlsbad, California • Downey, California • Fresno, California + 16 more